Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 6
2006 4
2007 7
2008 2
2009 3
2010 3
2011 4
2012 2
2013 2
2014 5
2015 5
2016 2
2017 5
2018 2
2019 2
2020 2
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, Casasnovas O, Brice P, van der Maazen R, Re A, Edeline V, Fermé C, van Imhoff G, Merli F, Bouabdallah R, Sebban C, Specht L, Stamatoullas A, Delarue R, Fiaccadori V, Bellei M, Raveloarivahy T, Versari A, Hutchings M, Meignan M, Raemaekers J. André MPE, et al. Among authors: raemaekers j. J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14. J Clin Oncol. 2017. PMID: 28291393 Clinical Trial.
Treatment of early-stage Hodgkin lymphoma.
Engert A, Raemaekers J. Engert A, et al. Among authors: raemaekers j. Semin Hematol. 2016 Jul;53(3):165-70. doi: 10.1053/j.seminhematol.2016.05.004. Epub 2016 May 12. Semin Hematol. 2016. PMID: 27496307 Review.
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.
Stevens WBC, Los-de Vries GT, Langois-Jacques C, Clear AJ, Stathi P, Sander B, Rosenwald A, Calaminici M, Hoster E, Hiddemann W, Gaulard P, Salles G, Klapper W, Xerri L, Burton C, Tooze RM, Smith AG, Buske C, Scott DW, Natkunam Y, Advani R, Sehn LH, Raemaekers J, Gribben J, Lockmer S, Kimby E, Kersten MJ, Maucort-Boulch D, Ylstra B, van Dijk E, de Jong D. Stevens WBC, et al. Among authors: raemaekers j. Hemasphere. 2023 Apr 5;7(4):e863. doi: 10.1097/HS9.0000000000000863. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37038467 Free PMC article. No abstract available.
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
Federico M, Fortpied C, Stepanishyna Y, Gotti M, van der Maazen R, Cristinelli C, Re A, Plattel W, Lazarovici J, Merli F, Specht L, Schiano de Colella JM, Hutchings M, Versari A, Edeline V, Stamatoulas A, Girinsky T, Ricardi U, Aleman B, Meulemans B, Tonino S, Raemaekers J, André M. Federico M, et al. Among authors: raemaekers j. J Clin Oncol. 2024 Jan 1;42(1):19-25. doi: 10.1200/JCO.23.01745. Epub 2023 Nov 15. J Clin Oncol. 2024. PMID: 37967311 Clinical Trial.
Angiogenesis in malignant lymphoma.
Koster A, Raemaekers JM. Koster A, et al. Among authors: raemaekers jm. Curr Opin Oncol. 2005 Nov;17(6):611-6. doi: 10.1097/01.cco.0000181404.83084.b5. Curr Opin Oncol. 2005. PMID: 16224242 Review.
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
Los-de Vries GT, Stevens WBC, van Dijk E, Langois-Jacques C, Clear AJ, Stathi P, Roemer MGM, Mendeville M, Hijmering NJ, Sander B, Rosenwald A, Calaminici M, Hoster E, Hiddemann W, Gaulard P, Salles G, Horn H, Klapper W, Xerri L, Burton C, Tooze RM, Smith AG, Buske C, Scott DW, Natkunam Y, Advani R, Sehn LH, Raemaekers J, Gribben J, Kimby E, Kersten MJ, Maucort-Boulch D, Ylstra B, de Jong D. Los-de Vries GT, et al. Among authors: raemaekers j. Blood Adv. 2022 Sep 27;6(18):5482-5493. doi: 10.1182/bloodadvances.2022008355. Blood Adv. 2022. PMID: 35816682 Free PMC article.
The EORTC strategy in the treatment of Hodgkin's lymphoma.
Eghbali H, Raemaekers J, Carde P; EORTC Lymphoma Group. Eghbali H, et al. Among authors: raemaekers j. Eur J Haematol Suppl. 2005 Jul;(66):135-40. doi: 10.1111/j.1600-0609.2005.00467.x. Eur J Haematol Suppl. 2005. PMID: 16007882 Review. No abstract available.
Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma.
Nijdam A, Dekker N, Aleman BMP, van 't Veer MB, Daniels LA, van der Maazen RW, Janus CPM, de Weijer RJ, Zijlstra JM, Stedema FG, Ta BD, Posthuma EFM, Manenschijn A, Dielwart MFH, Bilgin YM, van den Heuvel MJ, Boersma RS, van Leeuwen FE, Raemaekers JMM; BETER consortium. Nijdam A, et al. Among authors: raemaekers jmm. Br J Haematol. 2019 Aug;186(4):e103-e108. doi: 10.1111/bjh.15936. Epub 2019 May 15. Br J Haematol. 2019. PMID: 31090916 Free article. No abstract available.
Radiotherapy in advanced-stage Hodgkin's lymphoma.
Raemaekers JM, Aleman BM, Henry-Amar M. Raemaekers JM, et al. J Clin Oncol. 2005 Jan 1;23(1):245-6; author reply 246. doi: 10.1200/JCO.2005.99.122. J Clin Oncol. 2005. PMID: 15625384 No abstract available.
62 results